Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ralph Weissleder, Ph.D., M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Ralph Weissleder and Stephanie Dougan.
Ralph Weissleder
Connection Strength
0.093
Stephanie Dougan
  1. Anti-CTLA-4 therapy requires an Fc domain for efficacy. Proc Natl Acad Sci U S A. 2018 04 10; 115(15):3912-3917.
    View in: PubMed
    Score: 0.047
  2. PD-L1 is an activation-independent marker of brown adipocytes. Nat Commun. 2017 09 21; 8(1):647.
    View in: PubMed
    Score: 0.045
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.